Targeted gene therapies: tools, applications, optimization

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Critical reviews in biochemistry and molecular biology

• Publication date

  2012-04-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10409238.2012.658112PMID 22530743PMCID PMC3338207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosomes and cancer cells

  2011cited by this paper
• Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells

  2011cited by this paper
• Creating designed zinc-finger nucleases with minimal cytotoxicity.

  2011cited by this paper
• Reprogramming the pluripotent cell cycle: Restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells

  2011cited by this paper
• Preassembled zinc-finger arrays for rapid construction of ZFNs

  2011cited by this paper
• Genetic engineering of human ES and iPS cells using TALE nucleases

  2011cited by this paper
• Double-strand break end resection and repair pathway choice.

  2011cited by this paper
• Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

  2011cited by this paper
• Break-Induced Replication Is Highly Inaccurate

  2011cited by this paper
• DNA Nicks Promote Efficient and Safe Targeted Gene Correction

  2011cited by this paper
• Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes

  2011cited by this paper
• Tracking genome engineering outcome at individual DNA breakpoints

  2011cited by this paper
• Zinc-Finger Nucleases for Somatic Gene Therapy: The Next Frontier

  2011cited by this paper
• The reaction mechanism of FokI excludes the possibility of targeting zinc finger nucleases to unique DNA sites.

  2011cited by this paper
• TAL Effectors: Customizable Proteins for DNA Targeting

  2011cited by this paper
• Gene therapy for primary adaptive immune deficiencies.

  2011cited by this paper
• Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

  2011cited by this paper
• DNA Ligase III Promotes Alternative Nonhomologous End-Joining during Chromosomal Translocation Formation

  2011cited by this paper
• Interhomolog recombination and loss of heterozygosity in wild-type and Bloom syndrome helicase (BLM)-deficient mammalian cells

  2011cited by this paper
• In brief

  2011cited by this paper
• The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection*

  2011cited by this paper
• High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases

  2011cited by this paper
• An unbiased genome-wide analysis of zinc-finger nuclease specificity

  2011cited by this paper
• Gene therapy for keratin genodermatoses: striving forward but obstacles persist.

  2011cited by this paper
• A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity

  2011cited by this paper
• Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.

  2011cited by this paper
• Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase

  2011cited by this paper
• Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection

  2011cited by this paper
• A Tale of Two SCIDs

  2011cited by this paper
• Repair at Single Targeted DNA Double-Strand Breaks in Pluripotent and Differentiated Human Cells

  2011cited by this paper
• BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair.

  2011cited by this paper
• Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application

  2011cited by this paper
• Mining Endonuclease Cleavage Determinants in Genomic Sequence Data

  2011cited by this paper
• Assembly of custom TALE-type DNA binding domains by modular cloning

  2011cited by this paper
• H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes.

  2011cited by this paper
• Chemokine receptor 5 knockout strategies

  2011cited by this paper
• Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

  2011cited by this paper
• Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

  2011cited by this paper
• Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

  2011cited by this paper
• Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures

  2011cited by this paper
• Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI

  2011cited by this paper
• Native homing endonucleases can target conserved genes in humans and in animal models

  2011cited by this paper
• Identification of Genes Regulating Gene Targeting by a High-Throughput Screening Approach

  2011cited by this paper
• The consequences of structural genomic alterations in humans: genomic disorders, genomic instability and cancer.

  2011cited by this paper
• Engineering Designer Nucleases with Customized Cleavage Specificities

  2011cited by this paper
• Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells

  2011cited by this paper
• Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

  2011cited by this paper
• Tapping natural reservoirs of homing endonucleases for targeted gene modification

  2011cited by this paper
• Triplex technology in studies of DNA damage, DNA repair, and mutagenesis.

  2011cited by this paper
• Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways.

  2011cited by this paper
• H2AX Prevents CtIP-Mediated DNA End Resection and Aberrant Repair in G1-Phase Lymphocytes

  2010cited by this paper
• Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs.

  2010cited by this paper
• Targeted chromosomal deletions in human cells using zinc finger nucleases.

  2010cited by this paper
• Mechanisms of Recombination between Diverged Sequences in Wild-Type and BLM-Deficient Mouse and Human Cells

  2010cited by this paper
• Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases.

  2010cited by this paper
• Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion

  2010cited by this paper
• Origin of chromosomal translocations in lymphoid cancer.

  2010cited by this paper
• Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

  2010cited by this paper
• Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

  2010cited by this paper
• AAV's anatomy: roadmap for optimizing vectors for translational success.

  2010influential reference
• Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases

  2010cited by this paper
• Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4/ligase IV during chromosomal translocation formation

  2010cited by this paper
• 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.

  2010cited by this paper
• Gene therapy for β-thalassaemia: the continuing challenge

  2010cited by this paper
• Genome editing with engineered zinc finger nucleases

  2010cited by this paper
• Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

  2010cited by this paper
• Frequent endonuclease cleavage at off-target locations in vivo.

  2010cited by this paper
• Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

  2010cited by this paper
• Efficacy of gene therapy for X-linked severe combined immunodeficiency.

  2010cited by this paper
• Regulation of homologous recombination in eukaryotes.

  2010cited by this paper
• Dystrophin immunity in Duchenne's muscular dystrophy.

  2010cited by this paper
• Distinct factors control histone variant H3.3 localization at specific genomic regions.

  2010cited by this paper
• ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells

  2010cited by this paper
• Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

  2010cited by this paper
• Dynamic Dependence on ATR and ATM for Double-Strand Break Repair in Human Embryonic Stem Cells and Neural Descendants

  2010cited by this paper
• Sequence Conversion by Single Strand Oligonucleotide Donors via Non-homologous End Joining in Mammalian Cells*

  2010cited by this paper
• Autoimmunity in a genetic disease—a cautionary tale.

  2010cited by this paper
• Insulators and promoters: closer than we think

  2010cited by this paper
• 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

  2010cited by this paper
• Structure-guided reprogramming of serine recombinase DNA sequence specificity

  2010cited by this paper
• Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

  2010cited by this paper
• The discovery of zinc fingers and their applications in gene regulation and genome manipulation.

  2010cited by this paper
• Recent advances in lentiviral vector development and applications.

  2010cited by this paper
• Structure-based DNA-binding prediction and design.

  2010cited by this paper
• Targeting DNA Double-Strand Breaks with TAL Effector Nucleases

  2010cited by this paper
• Live-cell dSTORM with SNAP-tag fusion proteins

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells

  2010cited by this paper
• Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.

  2010cited by this paper
• Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template

  2010cited by this paper
• Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications.

  2010cited by this paper
• The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.

  2010cited by this paper
• Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases

  2009cited by this paper
• Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels

  2009cited by this paper
• High-resolution profiling of homing endonuclease binding and catalytic specificity using yeast surface display

  2009cited by this paper
• Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease

  2009cited by this paper
• Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*S⃞

  2009cited by this paper
• SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair

  2009cited by this paper
• XRCC2 and XRCC3 Regulate the Balance between Short- and Long-Tract Gene Conversions between Sister Chromatids

  2009cited by this paper
• Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection

  2009cited by this paper

• Exploring the cytotoxicity and DNA binding studies of green synthesized europium stannate nanoparticle through experimental and computational approach

  2025cites this paper
• CRISPR Cas 9 Technology: Future of Gene Editing

  2025cites this paper
• Cell membrane-engineered nanoparticles: A bionic platform for targeted cancer therapy.

  2025cites this paper
• In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology.

  2025cites this paper
• Cationic‐Hydrophilic Di‐Block Copolymers: Surface‐Shielded Vectors for Gene Delivery

  2025cites this paper
• Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer

  2024cites this paper
• Genome Editing Approaches Using Zinc Finger Nucleases (ZFNs) for the Treatment of Motor Neuron Diseases.

  2024cites this paper
• AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach

  2024cites this paper
• Biophysical and nuclear magnetic resonance spectroscopic studies of the binding of baicalein to DNA sequence d(CACGTG)2 and its cytotoxicity evaluation

  2024cites this paper
• Elucidation of the catalytic mechanism of a single-metal dependent homing endonuclease using QM and QM/MM approaches: the case study of I-PpoI.

  2024cites this paper
• Emerging Gene Therapeutics for Epidermolysis Bullosa under Development

  2024cites this paper
• Genome Editing Technologies and Application in Medicine: Discoveries, Challenges, and Prospects

  2023cites this paper
• Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening

  2023cites this paper
• Adeno-Associated Viral Vector Immobilization and Local Delivery from Bare Metal Surfaces.

  2022cites this paper
• Sequence-specific recognition of a coding segment of human DACH1 gene via short pyrimidine/purine oligonucleotides

  2021cites this paper
• Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era

  2021cites this paper
• Investigating the role of microglia in myelin development

  2021cites this paper
• Cracking the Monoubiquitin Code of Genetic Diseases

  2020cites this paper
• Applications and Improvements of CRISPR/Cas9 and Cas12a Gene Editing Technologies

  2020cites this paper
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

  2020cites this paper
• Genetik menschlicher Erkrankungen

  2020cites this paper
• Methods for Enhancing Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Mediated Homology-Directed Repair Efficiency

  2019cites this paper
• Sistema CRISPR/Cas y su aplicación a la edición dirigida de genomas

  2018cites this paper
• shRNA mediated inhibition of Cdc42 gene expression in Calu-6, lung cancer cells

  2017cites this paper
• Redox activated polymeric nanoparticles in tumor therapy

  2017cites this paper
• 1 shRNA mediated inhibition of Cdc 42 gene expression in Calu-6 , lung cancer cells Running title : shRNA mediated inhibition of Cdc 42 gene expression

  2017cites this paper
• RECQ5 promotes recombination and mutagenesis at targeted nicks through disruption of RAD51 filaments

  2016cites this paper
• Special Issue: Manifesting Synthetic Biology

  2015cites this paper
• The Potential of AAV-Mediated Gene Targeting for Gene and Cell Therapy Applications

  2015cites this paper
• Caractérisation du profil d'expression et des potentielles cibles off-targets d'un U7snRNA optimisé pour le traitement par saut d'exon de la Dystrophie Musculaire de Duchenne

  2015cites this paper
• Quantifying on- and off-target genome editing.

  2015cites this paper
• Star-Shaped Polypeptides: Synthesis and Opportunities for Delivery of Therapeutics.

  2015cites this paper
• Identification of off-target cleavage sites of zinc finger nucleases and TAL effector nucleases using predictive models.

  2014cites this paper
• Activation of betaglobin through the use of transcriptor activator-like effectors to combat sickle cell anemia

  2014cites this paper
• Biological Evaluation of Novel Pyridine derived Compounds - Exploring Cytotoxicity and Gene Targeting Activities

  2014influential citation
• Stimulation of Oligonucleotide-Directed Gene Correction by Redβ Expression and MSH2 Depletion in Human HT1080 Cells

  2014cites this paper
• Data-based core genes screening for Hepatocellular Carcinoma

  2014cites this paper
• Transient Alteration of Gene Expression in Adipose-Derived Stem Cells Using Liposomal-Driven Protein Extracts

  2014cites this paper
• Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery

  2014cites this paper
• Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.

  2013cites this paper
• Transient Alteration of Gene Expression in Adipose-Derived Stem Cells Using Liposomal-Driven Protein Extracts

  2013cites this paper
• Advancing the flatworm Macrostomum lignano as a versatile model organism for stem cell research

  2013cites this paper
• Computational and experimental analysis of TAL effector-DNA binding

  2013cites this paper
• TAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteins.

  2013cites this paper
• TAT-Mediated Delivery of Human Alanine:Glyoxylate Aminotransferase in a Cellular Model of Primary Hyperoxaluria Type I

  2013cites this paper
• Novel fluorescent genome editing reporters for monitoring DNA repair pathway utilization at endonuclease-induced breaks

  2013cites this paper
• Epigenetic Modification of the Repair Donor Regulates Targeted Gene Correction

  2012cites this paper